| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(78)90520-X |
| P698 | PubMed publication ID | 645744 |
| P50 | author | Robert P. Kimberly | Q41183568 |
| P2093 | author name string | H R Keiser | |
| P H Plotz | |||
| R E Bowden | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 804-807 | |
| P577 | publication date | 1978-05-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Reduction of renal function by newer nonsteroidal anti-inflammatory drugs | |
| P478 | volume | 64 |
| Q40153262 | 8Drug and chemical-induced metabolic acidosis |
| Q71605059 | A clinical assessment of the potential for pharmacological interaction between nimesulide and digoxin in patients with heart failure |
| Q37833916 | A review of non-steroidal anti-inflammatory drugs |
| Q68097368 | A survey of renal function in outpatients with rheumatoid arthritis |
| Q41133146 | Acute polyarticular gout |
| Q28317099 | Acute renal failure in an elderly woman following intramuscular ketorolac administration |
| Q40173254 | Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs on the Kidney |
| Q40678339 | Amphotericin B infusion-related toxicity: comparison of two- and four-hour infusions |
| Q35192912 | Analgesia in patients with ESRD: a review of available evidence |
| Q40323813 | Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. |
| Q68968948 | Analgesic-associated nephropathy |
| Q34783364 | Antagonistic effect of non-steroidal anti-inflammatory drugs on frusemide-induced diuresis in cardiac failure |
| Q40261830 | Anti-inflammatory agents as inhibitors of prostaglandin synthesis in man. |
| Q28325631 | Apparent acute renal failure associated with therapeutic aspirin and ibuprofen administration |
| Q40325362 | Assessment of nephrotoxicity |
| Q40811171 | Cirrhosis, renal function and NSAIDs |
| Q33556920 | Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study |
| Q45060810 | Decrease in urine output with diclofenac after total abdominal hysterectomy |
| Q70870825 | Disposition of azapropazone in chronic renal and hepatic failure |
| Q34708717 | Drug Prescribing in Renal Failure: Dosing Guidelines for Adults |
| Q40147819 | Drug-Induced Electrolyte Disorders |
| Q34038717 | Drug-induced hyperkalemia: old culprits and new offenders |
| Q70562527 | Effect of acetylsalicylic acid on renal function in systemic lupus erythematosus |
| Q68943443 | Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis |
| Q40261314 | Effect of indomethacin and adrenocorticotrophic hormone on renal function in man: An experimental model of inappropriate antidiuresis |
| Q69668222 | Effects of acute and chronic dosing of NSAIDs in patients with renal insufficiency |
| Q69767540 | Effects of dazmegrel, piroxicam and cyclophosphamide on the NZB/W model of SLE |
| Q34693363 | Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men. |
| Q39764359 | Effects of non-narcotic analgesics on the kidney. |
| Q70019035 | Effects of nonsteroidal antiinflammatory drugs on renal function in patients with renal insufficiency and in cirrhotics |
| Q68037779 | Evaluation of the renal injury from gold salts and nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis |
| Q42093547 | Fenclofenac induced interstitial nephritis confirmed by inadvertent rechallenge. |
| Q41426456 | Ibuprofen--past, present, and future. |
| Q34107261 | Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus |
| Q42262021 | Ibuprofen-induced meningitis in mixed connective tissue disease |
| Q28366935 | Ibuprofen: a severe systemic reaction |
| Q68745439 | Indomethacin does not impair cellular potassium uptake in the rat |
| Q41750062 | Indomethacin-induced hyperkalaemia |
| Q34554629 | Influence of non-steroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension |
| Q39927866 | Inhibition by clinically used dyes of prostaglandin inactivation in rat and human lung |
| Q35836120 | Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production |
| Q39559042 | Long-Term Efficacy and Safety of Tolmetin Sodium in Treatment of Geriatric Patients with Rheumatoid Arthritis and Osteoarthritis: A Retrospective Study |
| Q71657821 | Nephrotoxicity of nonsteroidal anti-inflammatory agents |
| Q36282905 | Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects |
| Q40902927 | Non-steroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors: a commonly prescribed combination with variable effects on renal function |
| Q42252667 | Non-steroidal anti-inflammatory drugs and the kidney |
| Q38137452 | Nonsteroidal antiinflammatory drugs. Renal toxicity. Review of pediatric issues |
| Q35573940 | Pain management in patients with chronic kidney disease |
| Q40091392 | Patient-reported Outcomes from A National, Prospective, Observational Study of Emergency Department Acute Pain Management With an Intranasal Nonsteroidal Anti-inflammatory Drug, Opioids, or Both |
| Q37944767 | Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs |
| Q40307279 | Pharmacokinetics of drug overdose |
| Q54100745 | Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly. |
| Q40256154 | Pharmacology, clinical efficacy, and adverse effects of piroxicam, a new nonsteroidal anti-inflammatory agent |
| Q40170807 | Problems of Antiarthritic Therapy in the Elderly |
| Q40139214 | Prostaglandins and anti-inflammatory drugs |
| Q39666831 | Prostaglandins in cardiovascular and renal function. Biochemical, physiological and clinical findings (author's transl) |
| Q40472860 | Renal Effects of Over‐the‐Counter Analgesics |
| Q34276925 | Renal consequences of nonsteroidal antiinflammatory drugs |
| Q40165238 | Renal effects of antipyretic analgesics |
| Q40299129 | Renal effects of drugs that inhibit prostaglandin synthesis |
| Q36717232 | Renal failure as a suspected adverse reaction to benoxaprofen |
| Q70606793 | Renal insufficiency associated with nonsteroidal anti-inflammatory agents |
| Q42270254 | Renal papillary necrosis due to ibuprofen |
| Q71707257 | Renal prostaglandins in cirrhosis |
| Q39503318 | Renal prostaglandins in systemic lupus erythematosus |
| Q28328381 | Reversible Renal Failure and Nephrotic Syndrome Associated with Nonsteroidal Anti-Inflammatory Drugs |
| Q54443600 | Role of prostaglandins and angiotensin II in experimental glomerulonephritis. |
| Q93808597 | Side effects of benoxaprofen |
| Q34559542 | Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure |
| Q39663245 | Stopping and restarting medications in the perioperative period |
| Q39666790 | The clinical significance of inhibition of renal prostaglandin synthesis |
| Q39537486 | Toxic interactions between lithium and non-steroidal anti-inflammatory drugs |
| Q70491862 | Use of ibuprofen in unusual circumstances |
| Q40086575 | Zomepirac Overdose and Review of Literature on Acute Toxicity of Nonsteroidal Antiinflammatory Agents |
| Q70278056 | [Renal failure caused by non-steroid anti-inflammatory agents] |
| Q72651962 | n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease |
Search more.